Skip to main content
SpringerLink
Log in

Completion Thyroidectomy: Revisited a Quarter of a Century Later

  • Endocrine Tumors
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

A Correction to this article was published on 12 February 2019

This article has been updated

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Change history

  • 12 February 2019

    In the original article’s XML file, Benzon M. Dy’s middle initial was tagged incorrectly. The error has been addressed with this correction.

References

  1. Ito Y, Miyauchi A, Inoue H, et al. An observational trial for papillary thyroid microcarcinoma in Japanese patients. World J Surg. 2010;34:28–35.

    Article  PubMed  Google Scholar 

  2. Ito Y, Miyauchi A, Kihara M, Higashiyama T, Kobayashi K, Miya A. Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation. Thyroid. 2014;24:27–34.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  3. Tuttle RM, Fagin JA, Minkowitz G, et al. Natural history and tumor volume kinetics of papillary thyroid cancers during active surveillance. JAMA Otolaryngol Head Neck Surg. 2017;143:1015–20.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Ritter K, Elfenbein D, Schneider DF, Chen H, Sippel RS. Hypoparathyroidism after total thyroidectomy: incidence and resolution. J Surg Res. 2015;197:348–53.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  5. Asari R, Passler C, Kaczirek K, Scheuba C, Niederle B. Hypoparathyroidism after total thyroidectomy: a prospective study. Arch Surg. 2008;143:132–7; discussion 138.

  6. Su A, Wang B, Gong Y, Gong R, Li Z, Zhu J. Risk factors of hypoparathyroidism following total thyroidectomy with central lymph node dissection. Med Baltimore. 2017;96:e8162.

    Article  Google Scholar 

  7. Kim SM, Kim HK, Kim KJ, et al. Recovery from permanent hypoparathyroidism after total thyroidectomy. Thyroid. 2015;25:830–33.

    Article  PubMed  CAS  Google Scholar 

  8. Shaha AR, Jaffe BM. Completion thyroidectomy: a critical appraisal. Surgery. 1992;112:1148–52; discussion 1152–43.

  9. Bilimoria KY, Bentrem DJ, Ko CY, et al. Extent of surgery affects survival for papillary thyroid cancer. Ann Surg. 2007;246:375–81; discussion 381–74.

  10. Hay ID, Grant CS, Bergstralh EJ, Thompson GB, van Heerden JA, Goellner JR. Unilateral total lobectomy: is it sufficient surgical treatment for patients with AMES low-risk papillary thyroid carcinoma? Surgery. 1998;124:958–64; discussion 964–56.

  11. Adam MA, Pura J, Goffredo P, et al. Impact of extent of surgery on survival for papillary thyroid cancer patients younger than 45 years. J Clin Endocrinol Metab. 2015;100:115–21.

    Article  PubMed  CAS  Google Scholar 

  12. Nixon IJ, Ganly I, Patel SG, et al. Thyroid lobectomy for treatment of well-differentiated intrathyroid malignancy. Surgery. 2012;151:571–79.

    Article  PubMed  Google Scholar 

  13. Duren M, Siperstein AE, Shen W, Duh QY, Morita E, Clark OH. Value of stimulated serum thyroglobulin levels for detecting persistent or recurrent differentiated thyroid cancer in high- and low-risk patients. Surgery. 1999;126:13–9.

    Article  PubMed  CAS  Google Scholar 

  14. Mazzaferri EL. An overview of the management of papillary and follicular thyroid carcinoma. Thyroid. 1999;9:421–27.

    Article  PubMed  CAS  Google Scholar 

  15. Nixon IJ, Patel SG, Palmer FL, et al. Selective use of radioactive iodine in intermediate-risk papillary thyroid cancer. Arch Otolaryngol Head Neck Surg. 2012;138:1141–46.

    Article  PubMed  Google Scholar 

  16. Hay ID, Hutchinson ME, Gonzalez-Losada T, et al. Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period. Surgery. 2008;144:980–7; discussion 987–8.

  17. Hay ID, Thompson GB, Grant CS, et al. Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940–1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients. World J Surg. 2002;26:879–85.

    Article  PubMed  Google Scholar 

  18. Hay ID, Bergstralh EJ, Goellner JR, et al. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery. 1993;114:1050–57; discussion 1057–58.

  19. Shaha AR, Loree TR, Shah JP. Intermediate-risk group for differentiated carcinoma of thyroid. Surgery. 1994;116:1036–40; discussion 1040–31.

  20. Cady B, Rossi R. An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery. 1988;104:947–53.

    PubMed  CAS  Google Scholar 

  21. Cranshaw IM, Carnaille B. Micrometastases in thyroid cancer: an important finding? Surg Oncol. 2008;17:253–58.

    Article  PubMed  Google Scholar 

  22. Chow SM, Law SC, Chan JK, Au SK, Yau S, Lau WH. Papillary microcarcinoma of the thyroid: prognostic significance of lymph node metastasis and multifocality. Cancer. 2003;98:31–40.

    Article  PubMed  Google Scholar 

  23. Lang BH, Lo CY, Chan WF, Lam KY, Wan KY. Staging systems for papillary thyroid carcinoma: a review and comparison. Ann Surg. 2007;245:366–78.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Paphavasit A, Thompson GB, Hay ID, et al. Follicular and Hurthle cell thyroid neoplasms: is frozen-section evaluation worthwhile? Arch Surg. 1997;132:674–78; discussion 678–80.

  25. Udelsman R, Westra WH, Donovan PI, Sohn TA, Cameron JL. Randomized prospective evaluation of frozen-section analysis for follicular neoplasms of the thyroid. Ann Surg. 2001;233:716–22.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  26. American Thyroid Association Guidelines Taskforce on Thyroid N, Differentiated Thyroid C, Cooper DS, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19:1167–214.

Download references

Author information

Authors and Affiliations

  1. Mayo Clinic, Breast, Endocrine, Metabolic and GI Surgery, Rochester, USA

    Benzon M. Dy MD

  2. Mayo Clinic, Surgery, Rochester, USA

    Veljko Strajina MD

  3. Department of Head and Neck Surgery, Memorial Sloan-Kettering Cancer Center, New York, USA

    Michael Tuttle MD & Ashok R. Shaha MD

Authors
  1. Benzon M. Dy MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Veljko Strajina MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Michael Tuttle MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ashok R. Shaha MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Benzon M. Dy MD.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

M. Dy, B., Strajina, V., Tuttle, M. et al. Completion Thyroidectomy: Revisited a Quarter of a Century Later. Ann Surg Oncol 26, 694–696 (2019). https://doi.org/10.1245/s10434-018-07102-z

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-018-07102-z

Search

Navigation